The effect of alcohol strength on alcohol consumption: a randomised controlled cross-over pilot trial by Perman-Howe, Parvati R. et al.
STUDY PROTOCOL Open Access
The effect of alcohol strength on alcohol
consumption: a randomised controlled
cross-over pilot trial
Parvati R. Perman-Howe1* , Emma L. Davies2 and David R. Foxcroft1
Abstract
Background: Effective interventions are required to reduce alcohol consumption and its associated harms at the
population level. Reducing the alcohol content of beverages has the potential to reduce alcohol consumption
through non-conscious processes. Before implementing a randomised controlled trial (RCT) to assess the effect of
alcohol strength on alcohol consumption, its feasibility needs to be established. This study aims to pilot a RCT and
obtain data to estimate key parameters required when designing a RCT. These key parameters include the direction
and size of the intervention effect, the efficacy and efficiency of the study processes and the rates of licenced
premises recruitment, participant recruitment and attrition.
Methods: A double-blind randomised controlled cross-over pilot trial comparing the number of units of reduced
strength lager consumed and the number of units of regular strength lager consumed in a single drinking occasion
within licenced premises in the UK.
Descriptive statistics will report the efficacy and efficiency of the study processes and the rates of licenced premises
recruitment, participant recruitment and attrition. Mean and 95% confidence intervals will be used to compare the
consumption of alcohol and the duration of participation in study sessions, between the intervention arm and the
control arm. The mean and standard deviation of UK units of alcohol consumed will be used to calculate a sample
size for a definitive RCT.
Discussion: This is the first naturalistic experimental study to assess the effect of alcohol strength on alcohol
consumption in a single drinking occasion within licenced premises. Results from this pilot study will establish the
feasibility of, and inform key data parameters for, a larger scale study.
Trial registration: The trial is registered in the American Economic Association (AEA) Randomised Controlled Trial
(RCT) Registry as of 16 June 2017. The unique identifying number is AEARCTR-0002266.
Keywords: Alcohol, Alcohol strength, Public health, Prevention, Intervention, Licenced premises, Pub, Bar, Pilot trial
Background
Excessive alcohol consumption is a causal factor for many
chronic health conditions, and it increases the risk of
intentional and non-intentional harm through violence
and injury [1, 2]. In 2015, there were 8758 avoidable
deaths in the United Kingdom (UK) that were directly
caused by alcohol [3]. A study with over 55,000 UK partic-
ipants found that of the 69% who reported drinking
alcohol, 27% reported drinking at levels that are classed as
high risk [4]. Moreover, 2.5 million people who regularly
drink alcohol report exceeding weekly alcohol thresholds
in a single drinking occasion [5]. The financial burden of
alcohol-related harm is estimated to annually cost UK
society betwen 1.3 and 2.7% gross domestic product
(GDP) [6].
The most effective alcohol harm prevention interventions
may be those that target non-conscious processes and that
are readily scalable to the population level [7–11]. These
include interventions that alter the properties or placement
of external stimuli, such as the strength of alcoholic
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products [10–12]. Such interventions could be particularly
beneficial within licenced premises where individuals may
not have direct access to information such as the strength
of alcoholic products. For example, lager “taps” often dis-
play a brand logo but do not incorporate information about
the strength of the product. Labelling drinks as lower in
strength has been shown to increase the amount of alcohol
consumed within a laboratory setting [13]. However, we
propose that when information about alcohol strength is
not forthcoming, such as when lager is purchased from the
“tap”, most consumers will not consciously seek this
information. Therefore, consumers cannot knowingly com-
pensate for drinking lower strength alcohol. Reducing the
alcohol content of popular lager products that are sold on
“tap”, or in other situations where information about
alcohol content is not readily available, may lead to a reduc-
tion in alcohol consumption. Interventions that utilise
non-conscious processes have the added benefit of poten-
tially reducing health inequalities as their recipients are not
required to be health literate and numerate or have
high-functioning cognition: lack of which are more preva-
lent with higher levels of deprivation [9, 14].
Reducing the alcohol content of drinks, thereby redu-
cing the number of alcohol units each drink comprises,
was proposed as a means to reduce alcohol consumption
by the UK Coalition Government (2010–2015) as part of
the Public Health Responsibility Deal (PHRD) [15].
Between 2011 and 2013, 1.3 billion UK units of alcohol
were removed from the UK market by reductions in the
alcohol content of beverages. This equates to the average
strength of beer falling from 4.42 to 4.14% alcohol by
volume (ABV) [16]. There is scope to further reduce the
ABV of alcohol in the UK market, but to date, there is
insufficient evidence that reducing the alcohol content of
drinks reduces the number of alcohol units consumed.
There is a paucity of studies that assess the effect of
the strength of alcohol on alcohol consumption within a
naturalistic setting. Most studies of alcohol strength are
strength discrimination studies. The majority of these
are laboratory based [17–21] and one study was based
within a mocked-up lounge in a community centre [22].
All but one incorporate beer, or beer and spirits, and a
single study focuses on wine [20]. These studies all sup-
port the hypothesis that people cannot readily distin-
guish between alcoholic products of different strength,
which indicates that there is potential to subconsciously
alter alcohol consumption by altering the ABV of alco-
holic products. An experiment with Canadian students
found that participants reported similar levels of enjoy-
ment and perceived intoxication after consuming an
equivalent volume of lower strength lager and regular
strength lager [23]. However, this study has numerous
limitations: it used a small sample of male students, it
was based within a classroom, and participants were
restricted to the amount of alcohol they could consume.
A more robust study that assessed the effect of the
strength of beer and mixed spirit-based drinks on con-
sumption supports the hypothesis that reducing the
alcohol content of drinks does not lead to an increase in
the volume of alcohol consumed, therefore reducing
consumption [24]. There were also limitations in this
study’s design, however, most notably that it was based
within closed student fraternity parties comprising a sin-
gle fraternity at one university in the United States of
America (USA) [24].
High-quality research is warranted to assess the effect
of alcohol strength on consumption within a naturalistic
environment. Prior to a definitive randomised controlled
trial (RCT), a pilot study is required to test feasibility
and estimate key parameters for the RCT’s design. This
study aims to determine the feasibility of a RCT, which
would assess whether people consume fewer units of
Bud Light lager 3.5% ABV (BL) compared to Becks lager
4.8% ABV (B) in a single drinking occasion within
licenced premises. The intervention product, BL, is one
of few mainstream lagers sold in the UK that is below
3.8% ABV, and it is reported to have retailed well since
its UK launch in March 2017 [25]. Results of a taste
discrimination experiment to establish a control product
for the pilot trial concluded that, out of a range of main-
stream regular strength lagers, B tasted the most similar
to BL (unpublished observations: Perman-Howe, Davies
and Foxcroft). To reduce confounding from difference
in taste, BL and B were therefore chosen as the interven-
tion and control products for the pilot trial.
The current study is defined as a randomised pilot
trial, in accordance with Eldridge et al.’s conceptual
framework for defining feasibility and pilot studies in
preparation for a RCT [26]. That is, the future RCT,
or parts of it, including the randomisation of partici-
pants, will be conducted on a smaller scale to see if
it can be done. It could also legitimately be called a
randomised feasibility study, but for clarity it will not
be referred to as a feasibility study [27]. Additionally,
and in line with Teare et al.’s definition of a pilot
study, it will provide data with which to estimate key
parameters for the design of a RCT [27]. It is an ex-
ternal pilot study: a stand-alone piece of work that
has been planned and will be carried out independ-
ently to a main study [28].
Methods/design
Aim/objectives
The overall aim of the study is to pilot a double-blind
randomised controlled cross-over trial to assess the
effect of alcohol strength on alcohol consumption. The
feasibility objectives are to establish whether:
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 Components of the study protocol are efficient and
work together or can be amended to be or do so
 A sufficient number of licenced premises can be
recruited to host the study
 The participant recruitment rate per study session is
sufficient
 Participant retention is sufficient
 The sample size derived from data obtained in the
study is achievable for a future definitive trial.
The participant-centred objective is to establish whether:
 Estimations of the mean and 95% confidence
intervals of the number of UK units of alcohol
consumed by participants in a single drinking
occasion support the hypothesis that people
consume fewer UK units of alcohol when they
consume reduced strength lager.
Design
The study is a double-blind randomised controlled AB/
BA cross-over pilot trial. The AB/BA cross-over design
means that each participant experiences both the inter-
vention and the control conditions, within a two-arm trial,
on separate occasions and in a randomised order. There
will be a four-week washout period between each partici-
pant´s study sessions, which is deemed adequate for
participants to have desensitised to the sensory aspects of
the alcohol they consumed in their first study session.
There is no risk of carryover effects from the alcohol
consumed during participants’ first study session, as alco-
hol is expelled from the body at the rate of approximately
one unit per hour. There is a possibility of period effects
as the characteristics of the participants may alter between
their two study sessions: this will be tested for using
a t test between the sequences AB and BA.
Setting
The pilot trial will be based within on-trade licenced prem-
ises in the South East of England, and London, UK. For
more information, refer to the “Recruitment of licenced
premises” section.
Participants
Fifty-two adults who regularly consume lager within
licenced premises will be recruited for the pilot trial. See
Table 1 for the Standard Protocol Items: Recommenda-
tions for Interventional Trials (SPIRIT).
Participants must meet all of the inclusion criteria and
not meet any of the exclusion criteria (Table 2).
Figure 1 illustrates the participants’ pathways through
the pilot trial.
Interventions
Intervention product
The intervention product is Bud Light lager 3.5% ABV.
It will be poured from 440-ml cans into a pint glass so
that a full pint (568 ml) is served. Participants may
consume the intervention product ad libitum during
their study sessions.
Table 1 Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) figure
Time point Study period
Enrolment Allocation Post-allocation Close-out
≥ 24 h before
study session 1
When participant
arrives for study
session 1
Study
session 1
End of study
session 1
When participant
arrives for study
session 2: 4 weeks
after study session 1
Study
session 2
End of study
session 2
Approx 48 h
after the final
study session
at the venue
Enrolment
Eligibility screen X
Consent X
Allocation X
Interventions
Bud Light X O
Becks O X
Assessments
BrAC reading X X X X
Time recorded X X X X
UK units of alcohol
consumed counted
X X
Questionnaire X X
Debrief email/letter X
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Control product
The control product is Becks lager 4.8% ABV. It will be
poured from 440-ml cans into a pint glass so that a full
pint (568 ml) is served. Participants may consume the
control product ad libitum during their study sessions.
Provision of intervention/control products
Before a study session, the principal investigator (PI:
PPH) will estimate the number of study-specific drinks
that will be required during the forthcoming session and
the corresponding number of 440-ml cans of BL and B
will be completely de-identified with duct tape.
The intervention and control products will be chilled
in a fridge 24 h before a study session.
Table 2 Inclusion/exclusion criteria
Inclusion Exclusion
≥ 18 years old Has ever sought help, or been
treated, for an alcohol dependency
Regular drinker of lager within a
licenced premises (≥ once in the
past three months)
Has an illness or condition with
which they should not be
consuming alcohol
Able to attend two study sessions Is on medication with which they
should not be consuming alcohol
Provides informed consent Pregnant
Has a BAC > 35 μg/100 ml breath
when they arrive for a study
session
µ
µ
Fig. 1 Participants’ pathways
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Participants will pay for study-specific drinks and
drink them ad libitum during a study session. The price
of the drinks will be specific to each venue and reflect a
small reduction (approximately 33%) in the normal price
for similar products at each venue: as participants will
not be able to choose their brand of lager and will not
know what brand they are purchasing.
When a participant wishes to purchase a study-specific
drink, they will go to a makeshift bar area that the re-
search assistant (RA: JW) will be manning. The RA will
exchange the participant’s money for BL or B and stamp
their randomisation card: a coloured square on the ran-
domisation card will refer to a coloured sticker on the
lager cans to notify the RA which cans to serve.
The drinks will be poured from 440-ml lager cans into
pint glasses so that a full pint is served: each pint will
therefore contain more than one can of lager. The RA
will be responsible for disposing of the empty cans and
giving the used glasses to the bar person (BP) to put into
the glass washer. The RA should not have to restock the
designated fridge space as the PI will ensure that the
fridge space is large enough to accommodate plentiful
alcohol for each study session: based on an estimation of
each participant drinking four pints.
Participants will be briefed that they may purchase
soft drinks from the normal bar area or be given free
tap water by the RA, but the only alcoholic drinks
they should purchase during a study session are the
study-specific lagers.
Discontinuing or modifying intervention/control products
The intervention and control products will not be re-
placed or modified during the pilot trial.
Outcome measures
The primary outcome is the feasibility of a RCT. A RCT
would be deemed feasible if it adheres to the following
points:
1. Components of the study protocol are efficient and
work together or can be amended to be or do so.
These include:
 The administration of data collection tools
 The consent process
 The randomisation process
 Data management processes
 The roles and requirements of study personnel
2. The licenced premise recruitment rate is a
minimum of one per month for a minimum of
4 months or until four licenced premises have been
recruited.
3. Participant recruitment rate is a minimum of four
per study session.
4. The rate of attrition for the pilot trial is less than or
equal to 30%, and this does not vary by more than
10% according to the arm of the trial.
5. The sample size is achievable to obtain within a
year based on the recruitment rate of licenced
premises and participants.
In addition, one participant-centred outcome will be
assessed:
1. Whether estimations of the mean and 95%
confidence intervals of the number of UK units of
alcohol consumed by participants in a single
drinking occasion, when they consume BL and B,
suggest that people consume fewer UK units of
alcohol when they consume reduced strength lager.
Sample size
As there are no data from previous studies on which to
base a statistical calculation, and there is no consensus
in the literature about the required sample size for pilot
trials, the sample size has been calculated using prelim-
inary datasets. These preliminary datasets are based on
the hypothesis that there is no significant difference
between the number of alcoholic drinks individuals con-
sume, regardless of their ABV, which has been shown in
a previous study [24].
Firstly, preliminary datasets were created for 40 patrons
at each of four different licenced premises with different
demographics, based on their average patron’s characteris-
tics, i.e. age and gender. The mean patrons’ age was calcu-
lated from each licenced premises’ preliminary dataset.
Mean age was used to estimate the number of units that
each of the 40 hypothetical patrons would consume under
normal conditions, based on age-related population data
for alcohol consumption [29]. The estimated number of
units consumed under normal conditions was reduced by
27% to give the estimated number of units consumed under
the intervention: the difference in ABV between BL and B
is − 27%. Estimated mean units and SD for units consumed
from BL and B were calculated; a conservative estimate for
SD in the intervention arm was used: the same SD as in the
control arm. Where the licenced premises’ population in-
corporated a higher proportion of male to female con-
sumers, this was accounted for in the calculations and the
mean consumption increased accordingly. From these data,
the estimated mean difference and SD of the mean differ-
ence of UK units of alcohol consumed were calculated.
These data enabled delta to be calculated, 0.3977.
Preliminary data for the licenced premises with the lar-
gest SD was used to calculate the sample size using the
Rstudio software ‘R Stats Package’ and the function
power.t.test [30]: this provided the most conservative cal-
culation of sample size. The figures that were inputted
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into Rstudio were alpha = 0.05, beta (power) = 0.8, delta =
0.3977, SD = 1. The sample size for a two-sided paired t
test was calculated as 52: 52 participants participating in
two trial arms. As this does not account for attrition, par-
ticipants who drop out of the pilot trial will be replaced.
Trial withdrawal
Participants who wish to withdraw from the study will
be directed to contact the PI via email or telephone or
express this to the PI verbally during a study session.
Participants who are seen by the PI, the RA or the BP to
be obviously and persistently breaching the protocol will be
withdrawn from the study. These breaches include consum-
ing any alcohol other than the study-specific lager which
they have purchased, supplying non-participants with
study-specific drinks, and disposing of any study-specific
lager without declaring it.
Definition of end of study
The study will officially end when the final participant has
been sent a debrief email/letter. If the pilot trial is deemed
to be eliciting too many adverse events, then the University
Research Ethics Committee (UREC) Chairperson may ter-
minate it early.
Recruitment
Recruitment of licenced premises
All licenced premises are eligible to participate regard-
less of whether they function under a premises licence
or a club premises certificate.
A minimum of one and maximum of six licenced
premises will be recruited via posts on Facebook and
Twitter; blogs on scientific forums; local newspaper,
magazine and radio advertisements; PI’s presentations at
local Pubwatch meetings; targeted emails to licenced
premises managers; and word of mouth. Recruitment
will work on a first come, first served basis.
Managers of licenced premises that contact the PI with
an expression of interest will be sent further details of
the study by email or post. If they wish to proceed there-
after, then a meeting will be arranged between the prem-
ises manager and the PI. If the PI regards the venue as
suitable to host the study, and the premises manager
wishes to proceed, both parties will agree on the dates
and times for a minimum of four study sessions. During
study sessions, the licenced premises will still be open to
the public. The licenced premises manager will sign a
letter of agreement for research access.
Recruitment of participants
Fifty-two participants will be recruited through posts on
the licenced premises social media accounts and through
placing flyers and posters within the premises.
The recruitment advertisements will ask people who
are interested to contact the PI via email or telephone.
Once a potential participant has contacted the PI, they
will be sent an invitation to participate in the study, a
participant information sheet (PIS) and a link to an
online eligibility survey. By default, these documents will
be sent electronically. The documents will be sent
through the post upon request with a stamped addressed
envelope.
Recruitment will commence two months before the
initial study session at each participating licenced
premises.
Recruitment will continue until the sample size (n = 52)
has been reached.
Recruitment will be monitored by the PI. The PI will
stop recruiting at a participating licenced premises if
either:
 The manager of the licenced premises expresses
they do not wish for any more study sessions to take
place (after the agreed four sessions)
 The licenced premises is failing to yield participants
at an adequate rate: less than four per study session
 It is no longer feasible for the licenced premises to
host the study
The PI may recruit from multiple participating li-
cenced premises at any one time, and this will be at their
discretion.
Screening
Potential participants will be screened to assess their
eligibility by completing an electronic survey using
Qualtrics software. The survey will be sent through the
post with a stamped addressed envelope upon request.
The PI will analyse the survey responses and contact
those who are eligible to arrange two study sessions.
Study sessions will be a month apart, on the same day of
the week and at the same start time.
Those who do not fulfil the eligibility criteria will be
sent an email or letter to thank them for expressing an
interest in the study and explaining the reason why they
are not eligible.
Consent procedure
When potential participants leave their contact details at
the end of the electronic screening survey, they consent
to their contact details being made available to the
research team and for them to be contacted in relation
to the study at any given time.
Individuals will take a breathalyser test when they ar-
rive for their first study session and those whose breath
alcohol concentration (BrAC) is equal to or below the
UK’s drink-drive limit, of ≤ 35 μg/100 ml breath, will be
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asked to complete a consent form. If the individual’s
BrAC exceeds this level, they will be told they cannot
take part in the study during the current session as they
may be too intoxicated to give informed consent.
Potential participants will be given the time they re-
quire to read the consent form (or have it read to them
by the PI), ask any questions and complete the form.
They will have received the PIS at least 48 h before their
study session, so their consent will be regarded as fully
informed.
Allocation
Sequence generation
Participants will be randomly assigned to the order that they
receive BL and B, using the AB/BA format, therefore coun-
terbalancing conditions. A separate computer-generated ran-
domisation sequence will be produced for each study venue
using Randomization.com software [31].
Concealment
The first “treatment” label (pink or purple) designated to
each subject in the randomisation sequence will be
translated as a discrete, coloured label on a randomisa-
tion card that will be concealed in a sealed and num-
bered opaque envelope. The sealed envelopes will be
placed in a pile, which will be overturned and placed
within a box once all envelopes are present so that the
sequence is in ascending numerical order.
Implementation
The chief investigator (CI: DF) will generate the alloca-
tion sequence and conceal the allocation. The PI will
enrol participants and assign them to the interventions
by asking them to take the next numbered envelope
from the sequence and opening it.
Blinding
The participants and the RA will be blinded to the inter-
vention and control products and the order in which
they are assigned. Due to limited study personnel, the PI
cannot be blinded.
Randomisation cards will display a colour-coded label,
and the participants and the RA will be unaware of the
colour-coding system. Coloured labels will be placed on
the de-identified lager cans that will correspond to the
coloured labels on the randomisation cards. The RA will
ask the participants to show their randomisation card
when they purchase a study-specific drink, and the
colour of the label on the card will inform the RA which
drink to serve.
Emergency un-blinding
In exceptional circumstances, whereby the participant’s
welfare would be compromised without the disclosure of
the alcohol product that they have consumed, the par-
ticipant and any other relevant persons will be
un-blinded to the intervention and/or control. Partici-
pants who are un-blinded will be removed from the
study. The PI will report all disclosures to the CI.
Data collection methods
Baseline measures
Participants’ BrACs will be measured at the start of each
of their study sessions with an Alcosense Pro Fuel Cell
Digital Breathalyser, using a one-way valve mouthpiece.
The breathalyser is accurate to − 0.00‰ BrAC, + 0.1‰
BrAC, and will be calibrated annually by Alcosense [32].
Data collection methods
The PI will maintain up-to-date records that cover point
1 in the “Outcome measures” section. Feedback from
members of the research team, participating licenced
premises and participants will be obtained and recorded
throughout the study.
Electronic datasets will be created in Excel to monitor:
 Licenced premises that are approached by the PI
 Landlords/managers who express willingness to
participate
 Landlords/managers who sign a letter of access
 Participants who consent to participate (and at each
separate participating licenced premises)
 Participants who consent and do not complete two
study sessions
 Participants who consent and drop out during or
after the intervention study session
 Participants who consent and drop out during or
after the control study session
To track the number of study-specific drinks served,
the RA will stamp the participant’s randomisation card
each time they are supplied with a fresh drink. The ran-
domisation card will be handed to the PI at the end of
each study session.
Participants will be briefed that if they do not consume
the entirety of a study-specific drink they should return
their drinking vessel to the RA. The RA will alert the PI
who will measure the amount of alcohol that has been
left in the vessel. The PI will quantify, in UK units, the
amount of alcohol that each participant has left through-
out each study session and deduct this from the number
of UK units of alcohol served to each participant, which
will be calculated by the PI. The number of UK units of
alcohol will be converted to, and additionally displayed
as, grams of alcohol for an international audience.
The PI will also record the times at which each partici-
pant commences and concludes each of their study ses-
sions. This will enable a comparison between the duration
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of participants’ study sessions under each of the study
conditions, which will indicate whether participants may
be concluding their study sessions and then consuming
non-study drinks.
Collecting data from deviant participants
Participants who are seen by the PI, the RA or the BP to
be obviously and persistently breaching the protocol will
be removed from the study, and their data will not be
utilised. Similarly, if a participant wishes to discontinue
in the pilot trial during a study session, no further data
will be collected.
Data analysis
The efficacy and efficiency of the study processes and
the rates of licenced premises recruitment, participant
recruitment and attrition will be analysed and reported
using descriptive statistics.
Mean value and 95% confidence intervals will be used
to compare the number of UK units of alcohol con-
sumed and the mean duration of participation in study
sessions, between the intervention arm and the control
arm.
The mean and SD of the number of UK units of alco-
hol consumed will be used to calculate a sample size for
future, larger scale studies. The components of the sam-
ple size calculation will be delta (mean difference/SD of
mean difference) = derived from a calculation of the
data, alpha (sig.level) = 0.05, beta (power) = 0.8.
A t test, between the sequences AB and BA, will be
undertaken to test for a period effect.
Monitoring
Safety/harms
There is no reason to believe that this study will lead to
an excessive number of adverse events. Although partici-
pants will be consuming alcohol, they will be briefed to
consume alcohol in their normal manner and processes
have been put in place to safeguard against study-related
harms. Any adverse events that are reported to the PI
will be logged using an adverse event form and reported
to the CI and the UREC Chairperson. It will be the
UREC Chairperson’s decision whether to terminate the
study should the number of adverse events reach a level
beyond which would be deemed unacceptable.
Participant confidentiality and access to data
Data will be de-identified, using a numerical code, where
this is feasible. The final anonymised trial dataset will be
made publically available in a repository as detailed in
the “Data handling, record keeping and retention” sec-
tion. In accordance with OBU’s Research Data Manage-
ment Policy, participants will remain anonymous in the
thesis and any publication(s) that result(s) from the
study [33].
Participants’ information will be used for research
purposes only and will only be accessed by the PI, the CI
and the co-investigator (Co-I: ED).
Data handling, record keeping and retention
Relevant information from electronic correspondence with
participants will be encrypted and saved in password-pro-
tected folders on an Oxford Brookes University (OBU) com-
puter’s hard drive and deleted from the email account. All
hard correspondence will be stored in a locked filing cabinet
within a lockable room at OBU.
All hard data collected at the study sites will be se-
curely transferred to locked filing cabinets within a lock-
able room at OBU at the first available opportunity
following each study session. Prior to this, it will be
stored in locked cabinet drawers at the PI’s residence.
Identifiable and non-identifiable information will be
transferred and stored separately.
Qualtrics [34] will host the eligibility surveys, with
whom OBU’s Faculty of Health and Life Sciences hold
an agreement. Identifiable data from the eligibility sur-
veys will be stored in encrypted and password-protected
Excel spreadsheets on an OBU computer’s hard drive.
If a participant withdraws from the study, then all of
their information will be destroyed.
Datasets will be kept in accordance with the General
Data Protection Regulation (GDPR) [35] and OBU’s
Research Data Management Policy [33]. The latter states
that study data will be offered and assessed for deposit
and retention in a University repository, such as the
Research Archive and Digital Asset Repository (RADAR).
Data on RADAR will be kept for a minimum of 10 years.
Data monitoring and auditing
Progress with data collection will be discussed by the PI,
the CI and the Co-I who will meet on a fortnightly basis.
OBU has procedures in place to audit students’ con-
duct during, and output from, their research. This audit
process will accommodate the current study, which is
part of a PhD programme.
Financing and insurance
Licenced premises incentives
Each licenced premises that hosts a minimum of four
study sessions will be given £500 via an invoice and bank
transfer. The licenced premises will also retain all of the
participants’ payments for study-specific drinks.
Participant incentives
Every participant who completes the trial will be automat-
ically entered into a free prize draw to win one of two
prizes of £100, delivered via bank transfer. Participants
Perman-Howe et al. Pilot and Feasibility Studies  (2018) 4:138 Page 8 of 11
can opt out of entry into the free prize draw by checking a
box on the consent form.
Legal liability/insurance
OBU has liability insurance for this research project.
Discussion
The aim of this pilot trial is to assess the feasibility of a
RCT to assess the effect of alcohol strength on alcohol
consumption in a single drinking occasion within li-
cenced premises; to our knowledge, no trials to date
have investigated this. If the pilot trial is successful, a
larger scale RCT could be undertaken, which would test
an intervention that has the potential to improve public
health by reducing alcohol consumption.
The pilot trial is of a cross-over design, which has the
advantages of eliminating between participant variation,
and being more economic due to a smaller sample. Whilst
there is no risk of a carryover effect, the main disadvan-
tage of using a cross-over design in this study is the poten-
tial for a period effect. This will be tested for during data
analysis and, if present, subsequently reported.
Whilst one of the main advantages of this study is its
naturalistic design, due to the complexity of undertaking
research within licenced premises, some compromises
have been necessary. For example, ideally the interven-
tion and control lagers would be supplied from “tapped”
barrels to align with how the majority of lager is sold to
customers within licenced premises. As this is not feas-
ible for a small-scale study, lager will be supplied from
duct-taped cans. Although this reduces the face validity
of the study, other measures have been put in place to
improve the study’s face validity. For instance, lager will
not be sold by the can but poured from multiple cans
into a pint glass so that a full pint is served.
There are some associated challenges that may be en-
countered during the pilot trial. These include recruiting
licenced premises, retention of participants across two
study sessions and participant adherence to the study
protocol. Processes that have been put in place to min-
imise these challenges are discussed below.
Recruiting licenced premises
A number of licenced premises managers who have been
given details of the pilot trial have expressed that their
business is tied to a brewery, meaning they are not at
liberty to sell any products on the premises that are not
provided by the brewery. If a licenced premises is tied to
a brewery, then it would be the responsibility of the
licenced premises manager to gain permission from the
brewery to host the study: to date, no manager has been
willing to do this. Therefore, recruitment has focused on
“free houses”, which are licenced premises that may ob-
tain stock from any supplier. In particular, free houses
that have links to members of the research team, that
are involved in local community or charitable projects,
or that function as bars within sports clubs have proven
particularly fruitful. Such licenced premises are more
likely to be incentivised by the financial gain: £500 plus
money from the sales of study-specific drinks.
Retention of participants
The two study sessions that participants are required to
attend will be one month apart to control for confound-
ing from day of the month, particularly around payday.
To reduce the chance of attrition, participants will be
sent reminder emails or letters one week and 24 h before
their second study session.
An additional concern is that participants may not like
the study-specific drink they have purchased and will
withdraw from the pilot trial during a study session. To
incentivise participants to remain in the pilot trial, and
continue to purchase study-specific drinks only, these
drinks will cost approximately one third less than the
cheapest lager sold within the venue. An additional
incentive of entry into a prize draw to win one of two
prizes of £100 has been included to reduce attrition.
Participant adherence to the study protocol
As participants will be free to mix with other partici-
pants and non-participants during their study sessions,
there is concern that they can easily obtain and consume
drinks other than that which they have been assigned to.
Encouraging groups of friends to participate in the study
together may reduce the risk of contamination, as every-
one within the group will be bound by the same rules
and restricted to study-specific drinks. Recruitment
advertisements will therefore reflect this strategy. Add-
itionally, participants will be reminded that if they do
not adhere to the protocol they will be withdrawn from
the study and lose the opportunity to win £100.
As this is a pilot trial, suitable changes will be im-
plemented if any unforeseen problems occur. These
will be discussed when assessing the feasibility of a
definitive RCT.
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